{"id":"https://openalex.org/W172695652","doi":null,"title":"Randomised phase III clinical trial of 5 different arms of treatment on 332 patients with cancer cachexia.","display_name":"Randomised phase III clinical trial of 5 different arms of treatment on 332 patients with cancer cachexia.","alternate_titles":[],"publication_year":2010,"publication_date":"2010-04-01","ids":{"openalex":"https://openalex.org/W172695652","mag":"172695652","pmid":"https://pubmed.ncbi.nlm.nih.gov/20496538"},"language":"en","primary_location":{"id":"pmid:20496538","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/20496538","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"European review for medical and pharmacological sciences","raw_type":"Clinical Trial, Phase III"},"parent_works":[],"lineage":["https://openalex.org/W172695652"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5070613250","display_name":"Gian Piero Mantovani","orcid":"https://orcid.org/0000-0002-3488-3425","observed_orcids":["https://orcid.org/0000-0002-3488-3425"]},"institutions":[{"id":"https://openalex.org/I172446870","display_name":"University of Cagliari","ror":"https://ror.org/003109y17","country_code":"IT","type":"education","lineage":["https://openalex.org/I172446870"]}],"countries":["IT"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"G Mantovani","raw_affiliation_strings":["Department of Medical Oncology, Schoool of Medicine, University of Cagliari, Italy. mantovan@medicina.unica.it"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medical Oncology, Schoool of Medicine, University of Cagliari, Italy. mantovan@medicina.unica.it","institution_ids":["https://openalex.org/I172446870"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5070613250"],"corresponding_institution_ids":["https://openalex.org/I172446870"],"apc_list":null,"apc_paid":null,"fwci":2.0351,"has_fulltext":false,"cited_by_count":51,"reviewed_by_count":0,"citation_normalized_percentile":{"value":0.84352774,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":86,"max":99},"biblio":{"volume":"14","issue":"4","first_page":"292","last_page":"301"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10397","display_name":"Nutrition and Health in Aging","score":0.9916999936103821,"subfield":{"id":"https://openalex.org/subfields/2737","display_name":"Physiology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10397","display_name":"Nutrition and Health in Aging","score":0.9916999936103821,"subfield":{"id":"https://openalex.org/subfields/2737","display_name":"Physiology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10858","display_name":"Clinical Nutrition and Gastroenterology","score":0.0015999999595806003,"subfield":{"id":"https://openalex.org/subfields/2916","display_name":"Nutrition and Dietetics"},"field":{"id":"https://openalex.org/fields/29","display_name":"Nursing"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10441","display_name":"Muscle Physiology and Disorders","score":0.0007999999797903001,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/cancer-cachexia","display_name":"cancer cachexia","score":0.9860000014305115},{"id":"https://openalex.org/keywords/medroxyprogesterone","display_name":"medroxyprogesterone","score":0.8859999775886536},{"id":"https://openalex.org/keywords/megestrol-acetate","display_name":"megestrol acetate","score":1.0},{"id":"https://openalex.org/keywords/eicosapentaenoic-acid","display_name":"eicosapentaenoic acid","score":0.9789999723434448},{"id":"https://openalex.org/keywords/l-carnitine","display_name":"L-carnitine","score":0.9940000176429749},{"id":"https://openalex.org/keywords/thalidomide","display_name":"thalidomide","score":0.9990000128746033},{"id":"https://openalex.org/keywords/combination-therapy","display_name":"combination therapy","score":0.796999990940094},{"id":"https://openalex.org/keywords/lean-body-mass","display_name":"lean body mass","score":0.9959999918937683},{"id":"https://openalex.org/keywords/resting-energy-expenditure","display_name":"resting energy expenditure","score":0.9990000128746033},{"id":"https://openalex.org/keywords/fatigue","display_name":"fatigue","score":0.9909999966621399},{"id":"https://openalex.org/keywords/appetite","display_name":"appetite","score":0.9399999976158142},{"id":"https://openalex.org/keywords/interleukin-6","display_name":"interleukin-6","score":0.925000011920929},{"id":"https://openalex.org/keywords/glasgow-prognostic-score","display_name":"Glasgow Prognostic Score","score":0.9739999771118164},{"id":"https://openalex.org/keywords/ecog-performance-status","display_name":"ECOG performance status","score":0.875},{"id":"https://openalex.org/keywords/exercise","display_name":"physical activity","score":0.5860000252723694},{"id":"https://openalex.org/keywords/pro-inflammatory-cytokines","display_name":"inflammatory cytokines","score":0.8209999799728394}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8623827695846558},{"id":"https://openalex.org/C2780723184","wikidata":"https://www.wikidata.org/wiki/Q6808975","display_name":"Megestrol acetate","level":3,"score":0.8102476596832275},{"id":"https://openalex.org/C2778654693","wikidata":"https://www.wikidata.org/wiki/Q254327","display_name":"Anorexia","level":2,"score":0.7233800888061523},{"id":"https://openalex.org/C2777704314","wikidata":"https://www.wikidata.org/wiki/Q6003455","display_name":"Cachexia","level":3,"score":0.6891893744468689},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5837770104408264},{"id":"https://openalex.org/C203092338","wikidata":"https://www.wikidata.org/wiki/Q1340863","display_name":"Clinical endpoint","level":3,"score":0.571709156036377},{"id":"https://openalex.org/C120863210","wikidata":"https://www.wikidata.org/wiki/Q17064264","display_name":"Lean body mass","level":3,"score":0.5018908977508545},{"id":"https://openalex.org/C75908981","wikidata":"https://www.wikidata.org/wiki/Q28578","display_name":"Appetite","level":2,"score":0.47851574420928955},{"id":"https://openalex.org/C2779951463","wikidata":"https://www.wikidata.org/wiki/Q7268788","display_name":"Quality of life (healthcare)","level":2,"score":0.46399399638175964},{"id":"https://openalex.org/C2779320873","wikidata":"https://www.wikidata.org/wiki/Q410513","display_name":"Megestrol","level":4,"score":0.4565746784210205},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.44819796085357666},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.44042155146598816},{"id":"https://openalex.org/C2775934596","wikidata":"https://www.wikidata.org/wiki/Q416667","display_name":"Medroxyprogesterone","level":4,"score":0.4365795850753784},{"id":"https://openalex.org/C168563851","wikidata":"https://www.wikidata.org/wiki/Q1436668","display_name":"Randomized controlled trial","level":2,"score":0.39070332050323486},{"id":"https://openalex.org/C2776306185","wikidata":"https://www.wikidata.org/wiki/Q2823834","display_name":"Medroxyprogesterone acetate","level":3,"score":0.24024468660354614},{"id":"https://openalex.org/C71315377","wikidata":"https://www.wikidata.org/wiki/Q11364","display_name":"Hormone","level":2,"score":0.11981844902038574},{"id":"https://openalex.org/C147583825","wikidata":"https://www.wikidata.org/wiki/Q620876","display_name":"Body weight","level":2,"score":0.06766301393508911},{"id":"https://openalex.org/C159110408","wikidata":"https://www.wikidata.org/wiki/Q121176","display_name":"Nursing","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001823","descriptor_name":"Body Composition","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D002100","descriptor_name":"Cachexia","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D002100","descriptor_name":"Cachexia","qualifier_ui":"Q000209","qualifier_name":"etiology","is_major_topic":true},{"descriptor_ui":"D002331","descriptor_name":"Carnitine","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D003278","descriptor_name":"Contraceptives, Oral, Hormonal","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D004734","descriptor_name":"Energy Metabolism","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008525","descriptor_name":"Medroxyprogesterone","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D008535","descriptor_name":"Megestrol","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009043","descriptor_name":"Motor Activity","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009369","descriptor_name":"Neoplasms","qualifier_ui":"Q000150","qualifier_name":"complications","is_major_topic":true},{"descriptor_ui":"D011379","descriptor_name":"Prognosis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013792","descriptor_name":"Thalidomide","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D015118","descriptor_name":"Eicosapentaenoic Acid","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D023381","descriptor_name":"Endpoint Determination","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"pmid:20496538","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/20496538","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"European review for medical and pharmacological sciences","raw_type":"Clinical Trial, Phase III"},{"id":"mag:172695652","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/20496538","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/randomized-controlled-trial","display_name":"Randomized Controlled Trial"},{"id":"https://openalex.org/study-designs/clinical-trial","display_name":"Clinical Trial"}],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2126536849","https://openalex.org/W2163227456","https://openalex.org/W2589391032","https://openalex.org/W1965754928","https://openalex.org/W2902040241","https://openalex.org/W1785092941","https://openalex.org/W2083081405","https://openalex.org/W2109348752","https://openalex.org/W2331891302","https://openalex.org/W2050763541"],"abstract_inverted_index":{"BACKGROUND":[0],"AND":[1],"OBJECTIVE:":[2],"A":[3,116],"phase":[4],"III":[5],"randomised":[6],"study":[7],"was":[8,221,250],"carried":[9],"out":[10],"to":[11,19,68],"establish":[12],"the":[13,21,98,113,121,127,251],"most":[14,230],"effective":[15,231],"and":[16,36,50,56,146,159,178,187,197,218,247],"safest":[17],"treatment":[18,114,226,232],"improve":[20],"primary":[22,131,236],"endpoints":[23,238,243],"of":[24,42,70,73,97,106,123,135],"cancer":[25],"cachexia:":[26],"lean":[27],"body":[28],"mass":[29],"(LBM),":[30],"resting":[31],"energy":[32,196,199],"expenditure":[33,200],"(REE),":[34],"fatigue;":[35],"relevant":[37],"secondary":[38,242],"endpoints:":[39],"appetite,":[40,244],"quality":[41],"life,":[43],"grip":[44],"strength,":[45],"Glasgow":[46],"Prognostic":[47],"Score":[48],"(GPS)":[49],"proinflammatory":[51],"cytokines.":[52],"PATIENTS:":[53],"Three":[54],"hundred":[55],"thirty-two":[57],"assessable":[58],"patients":[59],"with":[60,85],"cancer-related":[61],"anorexia/cachexia":[62],"syndrome":[63],"(CACS)":[64],"were":[65],"randomly":[66],"assigned":[67],"one":[69],"five":[71],"arms":[72,184,215],"treatment:":[74],"1--medroxyprogesterone":[75],"500":[76],"mg/d":[77],"or":[78],"megestrol":[79],"acetate":[80],"320":[81],"mg/d;":[82,94],"2--oral":[83],"supplementation":[84],"eicosapentaenoic":[86],"acid":[87],"(EPA);":[88],"3--L-carnitine":[89],"4":[90,102,186,217],"g/d;":[91],"4--thalidomide":[92],"200":[93],"5--a":[95],"combination":[96,252],"above.":[99],"Treatment":[100],"duration:":[101],"months.":[103],"RESULTS:":[104],"Analysis":[105],"variance":[107],"showed":[108,120,139,193],"a":[109],"significant":[110],"difference":[111],"between":[112,225],"arms.":[115,227],"post":[117],"hoc":[118],"analysis":[119,134],"superiority":[122],"arm":[124,154,164,170,176,204],"5":[125,177],"over":[126],"others":[128],"for":[129,233],"all":[130,234,256],"endpoints.":[132],"An":[133],"changes":[136],"from":[137],"baseline":[138],"that":[140,194,254],"LBM":[141],"(by":[142],"dual-energy":[143],"X-ray":[144],"absorptiometry":[145],"by":[147],"L3":[148],"computed":[149],"tomography)":[150],"significantly":[151,158,162,168,174,181,202,212],"increased":[152,167,201],"in":[153,163,169,175,183,203,214],"5.":[155,165,171,205],"REE":[156],"decreased":[157,173,182,213],"fatigue":[160],"improved":[161],"Appetite":[166],"IL-6":[172],"4.":[179],"GPS":[180,246],"5,":[185,216],"3.":[188,219],"Total":[189],"daily":[190],"physical":[191],"activity":[192],"total":[195],"active":[198],"Eastern":[206],"Cooperative":[207],"Oncology":[208],"group-Performance":[209],"Status":[210],"(ECOG-PS)":[211],"Toxicity":[220],"substantially":[222],"negligible,":[223],"comparable":[224],"CONCLUSIONS:":[228],"The":[229],"three":[235],"efficacy":[237],"as":[239,241],"well":[240],"IL-6,":[245],"ECOG":[248],"PS":[249],"regimen":[253],"included":[255],"selected":[257],"agents.":[258]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W172695652","counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2024,"cited_by_count":2},{"year":2023,"cited_by_count":1},{"year":2022,"cited_by_count":3},{"year":2021,"cited_by_count":8},{"year":2020,"cited_by_count":3},{"year":2019,"cited_by_count":4},{"year":2018,"cited_by_count":3},{"year":2017,"cited_by_count":2},{"year":2015,"cited_by_count":6},{"year":2014,"cited_by_count":6},{"year":2013,"cited_by_count":1},{"year":2012,"cited_by_count":8}],"updated_date":"2026-11-19T14:11:59.513116","created_date":"2016-06-24T00:00:00"}
